MC-Val-Cit-PAB-carfilzomib Size:Contact [email protected] for quotation Smiles: NC(=O)C1=CC(=CC=C1)C1=CC(=CC=C1)OC(=O)NC1CCCCC1

Smiles: NC(=O)C1=CC(=CC=C1)C1=CC(=CC=C1)OC(=O)NC1CCCCC1

and stress response genes

50% of mice (C57BL/6 mice bearing human papilloma virus (HPV) E6/7 TC-1 tumors) are tumor free 60 days after treatment with Protein E7(43-62)-polymeric nanoparticle (PC7A NP)

1 μM) or CB2 (Ki>10 μM) receptors in rat brain and spleen membranes

14bS)-4-carboxy-8a-({[(2R

MC-Val-Cit-PAB-carfilzomib Size:Contact [email protected] for quotation Smiles: NC(=O)C1=CC(=CC=C1)C1=CC(=CC=C1)OC(=O)NC1CCCCC1MC Val Cit PAB carfilzomib is a drug linker conjugate for ADC with potent antitumor activity by using carfilzomib (an irreversible proteasome inhibitor), linked via the ADC linker MC Val Cit PAB. Product information CAS Number: 2055896 83 6 Molecular Weight: 1275. 56 Formula: C68H96N11O13 Chemical Name: 4 ({4 [(2S) 5 (carbamoylamino) 2 [(2S) 2 [6 (2,5 dioxo 2,5 dihydro 1H pyrrol 1 yl)hexanamido] 3 methylbutanamido]pentanamido]phenyl}methyl) 4 ({[(1S)